Pharmaceutical care in dialysis services

Detalhes bibliográficos
Autor(a) principal: Santos Lula Barros, Débora
Data de Publicação: 2023
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Brasileira Multidisciplinar
Texto Completo: http://revistarebram.com/index.php/revistauniara/article/view/1233
Resumo: This study aimed to identify the types of clinical pharmaceutical services that are being developed, as well as the respective benefits produced for patients on dialysis. For that, the methodology of integrative review of scientific literature of the last 10 years was adopted. Studies published in Pubmed were recruited. After analyzing the scientific production according to the inclusion and exclusion criteria, five articles were retrieved. Several types of clinical pharmaceutical services were identified, with special emphasis on pharmacotherapeutic follow-up, which corresponded to the most mentioned category. Pharmacotherapy review services, drug reconciliation, user counseling and assessment / promotion of treatment adherence were also developed. Pharmaceutical care for dialysis patients resulted in increased satisfaction, quality of life, treatment adherence, hemoglobin and plasma calcium. Benefits were also found in reducing the following parameters: plasma phosphorus, interdialytic weight gain and blood pressure. Thus, clinical and humanistic contributions were found in the development of pharmaceutical care for patients on dialysis.
id UNIARA_ce17f4e0ae09d4f27aeb32f2fce143c4
oai_identifier_str oai:ojs.revistarebram.com:article/1233
network_acronym_str UNIARA
network_name_str Revista Brasileira Multidisciplinar
repository_id_str
spelling Pharmaceutical care in dialysis servicesCuidado farmacêutico nos serviços de diáliseevidence-based pharmacy practice. dialysis. drug utilization. pharmaceutical services.prática farmacêutica baseada em evidências. diálise. uso de medicamentos. assistência farmacêutica.This study aimed to identify the types of clinical pharmaceutical services that are being developed, as well as the respective benefits produced for patients on dialysis. For that, the methodology of integrative review of scientific literature of the last 10 years was adopted. Studies published in Pubmed were recruited. After analyzing the scientific production according to the inclusion and exclusion criteria, five articles were retrieved. Several types of clinical pharmaceutical services were identified, with special emphasis on pharmacotherapeutic follow-up, which corresponded to the most mentioned category. Pharmacotherapy review services, drug reconciliation, user counseling and assessment / promotion of treatment adherence were also developed. Pharmaceutical care for dialysis patients resulted in increased satisfaction, quality of life, treatment adherence, hemoglobin and plasma calcium. Benefits were also found in reducing the following parameters: plasma phosphorus, interdialytic weight gain and blood pressure. Thus, clinical and humanistic contributions were found in the development of pharmaceutical care for patients on dialysis.Esse estudo objetivou identificar os tipos de serviços farmacêuticos clínicos que estão sendo desenvolvidos, assim como os respectivos benefícios produzidos aos pacientes em diálise. Para tanto, foi adotada a metodologia da revisão integrativa da literatura científica dos últimos 10 anos. Foram recrutados os estudos publicados no Pubmed. Após a análise da produção científica segundo os critérios de inclusão e exclusão, foram recuperados cinco artigos. Foi identificada a realização de diversos tipos de serviços farmacêuticos clínicos, com destaque especial para o acompanhamento farmacoterapêutico, que correspondeu a categoria mais mencionada. Também foram desenvolvidos os serviços de revisão da farmacoterapia, a conciliação medicamentosa, o aconselhamento ao usuário e a avaliação/promoção da adesão ao tratamento. O cuidado farmacêutico ao paciente em diálise resultou no aumento da satisfação, da qualidade de vida, da adesão ao tratamento, da hemoglobina e do cálcio plasmático. Também foram encontrados benefícios na redução dos seguintes parâmetros: fósforo plasmático, ganho de peso interdialítico e pressão arterial. Assim, foram encontradas contribuições clínicas e humanísticas no desenvolvimento do cuidado farmacêutico ao paciente em diálise.Revista Brasileira Multidisciplinar - ReBraM2023-07-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://revistarebram.com/index.php/revistauniara/article/view/123310.25061/2527-2675/ReBraM/2023.v26i1.1233Revista Brasileira Multidisciplinar; v. 26 n. 1 (2023): Janeiro - Abril; 82-932527-26751415-3580reponame:Revista Brasileira Multidisciplinarinstname:Universidade de Araraquara (UNIARA)instacron:UNIARAporhttp://revistarebram.com/index.php/revistauniara/article/view/1233/890Copyright (c) 2023 Revista Brasileira Multidisciplinar - ReBraMhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSantos Lula Barros, Débora2024-02-16T23:44:46Zoai:ojs.revistarebram.com:article/1233Revistahttp://revistarebram.com/index.php/revistauniaraPRIhttps://revistarebram.com/index.php/revistauniara/oairevistauniara@uniara.com||2527-26752527-2675opendoar:2024-02-16T23:44:46Revista Brasileira Multidisciplinar - Universidade de Araraquara (UNIARA)false
dc.title.none.fl_str_mv Pharmaceutical care in dialysis services
Cuidado farmacêutico nos serviços de diálise
title Pharmaceutical care in dialysis services
spellingShingle Pharmaceutical care in dialysis services
Santos Lula Barros, Débora
evidence-based pharmacy practice. dialysis. drug utilization. pharmaceutical services.
prática farmacêutica baseada em evidências. diálise. uso de medicamentos. assistência farmacêutica.
title_short Pharmaceutical care in dialysis services
title_full Pharmaceutical care in dialysis services
title_fullStr Pharmaceutical care in dialysis services
title_full_unstemmed Pharmaceutical care in dialysis services
title_sort Pharmaceutical care in dialysis services
author Santos Lula Barros, Débora
author_facet Santos Lula Barros, Débora
author_role author
dc.contributor.author.fl_str_mv Santos Lula Barros, Débora
dc.subject.por.fl_str_mv evidence-based pharmacy practice. dialysis. drug utilization. pharmaceutical services.
prática farmacêutica baseada em evidências. diálise. uso de medicamentos. assistência farmacêutica.
topic evidence-based pharmacy practice. dialysis. drug utilization. pharmaceutical services.
prática farmacêutica baseada em evidências. diálise. uso de medicamentos. assistência farmacêutica.
description This study aimed to identify the types of clinical pharmaceutical services that are being developed, as well as the respective benefits produced for patients on dialysis. For that, the methodology of integrative review of scientific literature of the last 10 years was adopted. Studies published in Pubmed were recruited. After analyzing the scientific production according to the inclusion and exclusion criteria, five articles were retrieved. Several types of clinical pharmaceutical services were identified, with special emphasis on pharmacotherapeutic follow-up, which corresponded to the most mentioned category. Pharmacotherapy review services, drug reconciliation, user counseling and assessment / promotion of treatment adherence were also developed. Pharmaceutical care for dialysis patients resulted in increased satisfaction, quality of life, treatment adherence, hemoglobin and plasma calcium. Benefits were also found in reducing the following parameters: plasma phosphorus, interdialytic weight gain and blood pressure. Thus, clinical and humanistic contributions were found in the development of pharmaceutical care for patients on dialysis.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-17
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://revistarebram.com/index.php/revistauniara/article/view/1233
10.25061/2527-2675/ReBraM/2023.v26i1.1233
url http://revistarebram.com/index.php/revistauniara/article/view/1233
identifier_str_mv 10.25061/2527-2675/ReBraM/2023.v26i1.1233
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv http://revistarebram.com/index.php/revistauniara/article/view/1233/890
dc.rights.driver.fl_str_mv Copyright (c) 2023 Revista Brasileira Multidisciplinar - ReBraM
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Revista Brasileira Multidisciplinar - ReBraM
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Revista Brasileira Multidisciplinar - ReBraM
publisher.none.fl_str_mv Revista Brasileira Multidisciplinar - ReBraM
dc.source.none.fl_str_mv Revista Brasileira Multidisciplinar; v. 26 n. 1 (2023): Janeiro - Abril; 82-93
2527-2675
1415-3580
reponame:Revista Brasileira Multidisciplinar
instname:Universidade de Araraquara (UNIARA)
instacron:UNIARA
instname_str Universidade de Araraquara (UNIARA)
instacron_str UNIARA
institution UNIARA
reponame_str Revista Brasileira Multidisciplinar
collection Revista Brasileira Multidisciplinar
repository.name.fl_str_mv Revista Brasileira Multidisciplinar - Universidade de Araraquara (UNIARA)
repository.mail.fl_str_mv revistauniara@uniara.com||
_version_ 1797174604342493184

Registros relacionados